1. Papillary Carcinoma of the Thyroid: High Expression of COX-2 and Low Expression of KAI-1/CD82 Are Associated with Increased Tumor Invasiveness
- Author
-
Stefania, Scarpino, Enrico, Duranti, Giglio, Simona, DI NAPOLI, Arianna, Dino, Galafate, Donatella Del Bufalo, Marianna, Desideri, Socciareli, F., Fabio, Socciarelli, Stoppacciaro, Antonella, and Ruco, Luigi
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Primary Cell Culture ,Mice, Nude ,Biology ,Kangai-1 Protein ,Transfection ,Young Adult ,Endocrinology ,Downregulation and upregulation ,Cell Movement ,Cell Line, Tumor ,medicine ,Tumor Cells, Cultured ,Animals ,Humans ,Metastasis suppressor ,Neoplasm Invasiveness ,Thyroid Neoplasms ,Aged ,Cyclooxygenase 2 Inhibitors ,Thyroid ,Carcinoma ,Cell migration ,Middle Aged ,Carcinoma, Papillary ,medicine.anatomical_structure ,Cell culture ,Cyclooxygenase 2 ,Thyroid Cancer, Papillary ,Lymphatic Metastasis ,Cancer research ,Hepatocyte growth factor ,Female ,CD82 ,medicine.drug ,Signal Transduction - Abstract
We have previously demonstrated that expression of COX-2 is upregulated by hepatocyte growth factor in thyroid papillary carcinoma (TPC) cells and is associated with increased invasiveness of tumor cells. COX-2 upregulation was associated with downregulation of KAI-1/CD82, a metastasis suppressor molecule that has been associated with the metastatic potential of several solid tumors. In the present study, we have investigated the possibility that downregulation of KAI-1/CD82 may contribute to the invasiveness of papillary carcinoma cells.Expression of KAI-1/CD82 and its relation to COX-2 levels were investigated in 6 primary cultures of TPC, in 2 tumor cell lines (TPC-1 and K1), and in 55 tumor samples of TPC. The biological role of KAI-1/CD82 in regulating tumor invasiveness was investigated in TPC cell lines and primary cultures transfected with a pCDNA3.1/Hygro.KAI-1; transfected cells were tested in functional studies of cell migration and invasiveness. Finally, the role of KAI-1/CD82 in influencing TPC metastasis was investigated in vivo using nu/nu mice injected with K1-transfected cells.We provide evidence that COX-2 and KAI-1/CD82 are inversely regulated in TPC primary cultures and in TPC-1 tumor cells. In fact, inhibition of COX-2 with NS398 is associated with a 2-9-fold upregulation of KAI-1/CD82 RNA. Moreover, a possible relation between COX-2 and KAI-1/CD82 was confirmed by the presence of a statistically significant inverse correlation in the expression of the two genes in 55 tumor samples of TPC (r = -0.513; p = 0.001). In 36 of 55 cases, tumor areas contained lower levels of KAI-1/CD82 RNA as compared with the corresponding normal tissue. Low expression of KAI-1/CD82 RNA in the tumor area was associated with extrathyroid extension of the disease in 16 of 19 cases (p0.04) and with lymph node metastasis in 11 of 14 cases (not significant). KAI-1/CD82 re-expression in tumor cells was associated with a significant decrease in their migratory (50-76% reduction) and invasive (46-65% reduction) capacity, even after hepatocyte growth factor stimulation. Finally, nu/nu mice injected with KAI-1/CD82-transfected K1 TPC cells developed fewer and smaller metastasis as compared with mice injected with vector-transfected K1 cells (p=0.016).Our findings raise the possibility that downregulation of KAI-1/CD82 in TPC cells is one of the molecular mechanisms regulating their invasive and metastatic potential.
- Published
- 2013